Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07256665 · ClinicalTrials.gov registry record · NA

The Cracking Consciousness Study With Monroe & Neuphoria

A NA study, sponsored by Efforia.

Completed
Registry status
NA
Development phase
271
Enrollment target

NCT07256665 is a NA study that has completed, run by Efforia. The registered enrollment target is 271 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07256665, a NA study, has completed, sponsored by Efforia.

COMPLETED
Registry status
NA
Development phase
271 participants
Enrollment target

Study Summary

You've explored the Monroe Focus levels. But, Bob Monroe said, "You might believe something, but you won't understand it until you can measure it with objective data." Now, for the first time, we can measure them. In partnership with Neuphoria, we're launching a groundbreaking EEG study to define Higher States of Consciousness. Join the World's First higher states of Consciousness Study.

Interventions

  • DEVICE Neuphoria Wearable

Trial Details

FieldValue
Enrollment Target 271 participants
Start Date 2025-08-10
Est. Completion 2026-01-10
Phase NA

Sponsor

Efforia

19 total trials

What the Registry Record Tells You About NCT07256665

The ClinicalTrials.gov registry entry for NCT07256665 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 271 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Efforia, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Neuphoria Wearable is the first listed.

NCT07256665 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07256665 about?

NCT07256665 is a clinical study titled "The Cracking Consciousness Study With Monroe & Neuphoria". You've explored the Monroe Focus levels. But, Bob Monroe said, "You might believe something, but you won't understand it until you can measure it with objective data." Now, for the first time, we can measure them. In partnership with Neuphoria, we're launching a groundbreaking EEG study to define Hi...

What is the current status of trial NCT07256665?

This trial is currently completed. It is a NA study. The enrollment target is 271 participants. The study started on 2025-08-10. Estimated completion is 2026-01-10.

What interventions are being tested in trial NCT07256665?

The interventions under investigation include: Neuphoria Wearable (DEVICE).

Who is sponsoring clinical trial NCT07256665?

This trial is sponsored by Efforia, which has 19 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.